Search results
Moderna (MRNA) Set to Announce Earnings on Thursday
ETF DAILY NEWS· 10 hours agoModerna (NASDAQ:MRNA – Get Free Report) will be releasing its earnings data before the market opens on Thursday, May 2nd. Analysts expect Moderna to post earnings of ($3.36 ...
mRNA Is Promising A Breakthrough In Fighting Cancer
Benzinga via Yahoo Finance· 2 days agoWhen it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 6 days agoModerna's solid trial data makes me optimistic the FDA will offer mRNA-1345 a nod, so the company soon may have two products on the market -- and be...
Naviter Wealth LLC Sells 3,036 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 5 hours agoThe institutional investor owned 21,557 shares of the biopharmaceutical company’s stock after selling 3,036 shares during the period. Naviter Wealth LLC’s holdings in Pfizer ...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 7 hours agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Zacks via Yahoo Finance· 5 days agoOver the past six months, shares of MRNA have risen 36.47%. (See the last biotech stock roundup...
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 1 day agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals in 2023 ...
A Fed meeting, jobs report, and more Big Tech earnings: What to know this week
Yahoo Finance· 3 days ago...Coinbase (COIN), Cigna (CI), ConocoPhillips (COP), DraftKings (DKNG), Expedia (EXPE), Moderna (...
Leerink Partnrs Weighs in on Cartesian Therapeutics, Inc.’s Q1 2024 Earnings (NASDAQ:RNAC)
ETF DAILY NEWS· 6 days agoCartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) – Research analysts at Leerink Partnrs issued their Q1 2024 earnings estimates for Cartesian Therapeutics in a report released on Tuesday ...
